UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating
瑞銀將10倍基因組學目標股價從44美元調整至52美元，維持中性評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊